SIRP'alpha' SHP1 gene expression in peripheral blood monocytes and U937 myelomonocytic cells and its role in autoimmune hemolytic anemia (2006)
- Authors:
- Autor USP: CONDINO NETO, ANTONIO - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Language: Inglês
- Abstract: Introduction and Objectives: The interaction between macrophage SIRP and erythrocyte CD47 results in SHP1 recruitment, leading to inhibition of phagocytosis. In Autoimmune Hemolytic Anemia (AIHA), erythrocytes are coated with auto-antibody and cleared. We consider that a failure in phagocytosis inhibition could contribute to the disease. Our objective was to investigate the expression of SIRP and SHP1 in AIHA patients' peripheral blood monocytes (PBM), and the effects of IFNã/TNF (IT) and dexamethasone (DX - first choice treatment) on their expression in healthy PBM and U937 cells. Methods: SIRP and SHP1 gene expression from AIHA PBM (n=6), U937 cells (n=6) and healthy PBM (n=5) cultured during 72h with IT and/or DX was determined by Real Time PCR. Results: PBM: AIHA express more SIRP (Mean ± SD, 15,88 ± 5,43) and SHP1 (12,99 ± 3,85) than healthy PBM cultured in basal conditions (control; SIRPa 6,25 ± 5,72; SHP1 6,42 ± 4,10); Compared to control PBM, DX increases SIRP (24,87 ± 12,02) and SHP1 (19,12 ± 6,23) gene expression; IT alone do not increase significantly SIRP (14,94 ± 9,03) or SHP1 (12,31 ± 7,13) gene expression, but when associated with DX, it potentiates DX effect over both gene expression (SIRP 58,26 ± 37,79; SHP1 27,12 ± 18,44). U937 cells:Compared to control cells (1,58 ± 0,50), IT and/or DX treatment increases SHP1 gene expression (DX 4,71 ± 1,96; IT 12,67 ± 7,16; DXIT 8,17 ± 4,70), while SIRP gene expression (control 1,97 ±1,41) increases after IT (6,10 ± 3,62) or DXIT (3,74 ± 1,22) treatment, but not with DX alone (4,87 ± 4,71); All U937 cells treatments show smaller SIRP gene expression than AIHA, but SHP1 gene expression is the same as AIHA after IT or DXIT treatment. SIRP and SHP1 gene expression are bigger in PBM than in U937 cells, except after IT treatment. Conclusion: Increased SIRP and SHP1 gene expression in AIHA can be a homeostatic mechanism to increased erythrophagocytosis. DX increases SIRP and SHP1 gene expression in PBM, a possible mode of action for the reduction of erythrophagocytosis. SIRP and SHP1 gene expression increases during myelomonocytic cell maturation process, and after maturation they become more susceptible to DX stimuli.
- Imprenta:
- Source:
- Título do periódico: Abstracts
- Conference titles: Meeting of the Brazilian Society for Immunology
-
ABNT
ALMEIDA, A C et al. SIRP'alpha' SHP1 gene expression in peripheral blood monocytes and U937 myelomonocytic cells and its role in autoimmune hemolytic anemia. 2006, Anais.. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2006. . Acesso em: 24 abr. 2024. -
APA
Almeida, A. C., Barjas-Castro, M. L., Saad, S. T., Rehder, J., & Condino-Neto, A. (2006). SIRP'alpha' SHP1 gene expression in peripheral blood monocytes and U937 myelomonocytic cells and its role in autoimmune hemolytic anemia. In Abstracts. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Almeida AC, Barjas-Castro ML, Saad ST, Rehder J, Condino-Neto A. SIRP'alpha' SHP1 gene expression in peripheral blood monocytes and U937 myelomonocytic cells and its role in autoimmune hemolytic anemia. Abstracts. 2006 ;[citado 2024 abr. 24 ] -
Vancouver
Almeida AC, Barjas-Castro ML, Saad ST, Rehder J, Condino-Neto A. SIRP'alpha' SHP1 gene expression in peripheral blood monocytes and U937 myelomonocytic cells and its role in autoimmune hemolytic anemia. Abstracts. 2006 ;[citado 2024 abr. 24 ] - Anhidrotic ectodermal dysplasia and T cell immunodeficiency
- BAY 41-2272 aumenta a atividade microbicida in vitro de leucócitos mononucleares humanos
- The role of nuclear factor kappa B (NF-kB) on the NCF1 gene expression
- Essential role of nuclear factor-kappa B for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes
- A single nucleotide polymorphism in the promoter region of the NCF-2 gene
- Essential role of nuclear factor-kappa B for NADPH oxidase activity, CYBB and NCF-1 gene expression in normal and anhidrotic ectodermal dysplasia leukocytes
- An unusual case of a female patient presenting with recurrent infections due to mycobacteria, viruses, and pyogenic bacteria and defective TLRs response
- Critical issues and needs in management of primary immunodeficiency diseases in Latin America
- Brain abscess as first clinical manifestation of hypogammaglobulinemia
- Essential role of Nuclear Factor kappa B (NF-jB) on NCFL gene expression in normal, anhidrotic ectodermal dysplasia, and chronic granulomatous disease leukocytes
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
